MOLINELLI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 3.599
EU - Europa 1.555
AS - Asia 563
AF - Africa 102
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 5.840
Nazione #
US - Stati Uniti d'America 3.587
IT - Italia 439
IE - Irlanda 260
CN - Cina 253
SE - Svezia 230
SG - Singapore 205
UA - Ucraina 166
FR - Francia 136
DE - Germania 99
CI - Costa d'Avorio 74
GB - Regno Unito 72
DK - Danimarca 44
IN - India 34
FI - Finlandia 33
TR - Turchia 32
MA - Marocco 28
KR - Corea 23
RU - Federazione Russa 20
BE - Belgio 15
NL - Olanda 15
CA - Canada 9
JP - Giappone 9
BR - Brasile 8
GR - Grecia 7
TH - Thailandia 5
AT - Austria 4
CL - Cile 3
EU - Europa 3
MX - Messico 3
PE - Perù 3
PT - Portogallo 3
AU - Australia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
PL - Polonia 2
SM - San Marino 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
LI - Liechtenstein 1
TW - Taiwan 1
Totale 5.840
Città #
Chandler 629
Des Moines 339
Ashburn 309
Dublin 251
Boardman 250
Fairfield 232
Jacksonville 189
New York 136
Seattle 109
Wilmington 107
Woodbridge 91
Singapore 87
Houston 83
Lawrence 83
Princeton 83
Abidjan 74
Cambridge 72
Ann Arbor 62
San Mateo 62
Centro 57
San Diego 40
Turin 39
Washington 38
Ancona 34
Los Angeles 32
Pune 32
Boydton 28
Guangzhou 28
London 24
Shanghai 24
Wuhan 24
Rome 16
Brussels 15
Tolentino 15
Marche 14
Beijing 13
Helsinki 13
Dallas 12
Civitanova Marche 9
Menlo Park 9
Moscow 9
Ascoli Piceno 8
Dronten 8
Jiaxing 8
Kilburn 8
Norwalk 8
Wuxi 8
Falls Church 7
Cagliari 6
Falconara Marittima 6
Pesaro 6
Redmond 6
Redwood City 6
Bangkok 5
Clifton 5
Comunanza 5
Huskvarna 5
Iesi 5
Jinhua 5
Milan 5
New Bedfont 5
Prescot 5
Yiwu 5
Acton 4
Frankfurt am Main 4
Gainesville 4
Hangzhou 4
Heze 4
Ottawa 4
Polverigi 4
Southwark 4
Arzano 3
Bari 3
Carini 3
Filottrano 3
Gatchina 3
Genoa 3
Guarulhos 3
Hanover 3
Munich 3
Nanjing 3
Nantong 3
Novara 3
Perugia 3
Quanzhou 3
Reggio Emilia 3
San Bernardo 3
Toronto 3
Venegono Superiore 3
Vienna 3
Birmingham 2
Bolzano 2
Borgo Maggiore 2
Castello di Godego 2
Cingoli 2
Dongyang 2
Folignano 2
Fuzhou 2
Hackney 2
Lisbon 2
Totale 4.017
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 203
Involvement of the oral cavity in psoriasis: results of a clinical study 118
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 109
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 97
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 94
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 88
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 88
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 86
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 83
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 83
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 82
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 81
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 79
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 78
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 78
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 77
Review: A safety profile of dalbavancin for onand off-label utilization 77
Biologic Therapy in Psoriasis: Safety Profile 75
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 74
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 74
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 73
Oxidative stress and alterations of paraoxonases in atopic dermatitis 72
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 71
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 70
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 70
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 69
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 69
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 68
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 67
Mycosis Fungoides-like Eruption and Infliximab 67
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 65
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 64
Relapsing acute generalized exanthematous pustolosis: a guess. 63
Reticulated acanthoma with sebaceous differentiation 63
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 63
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 63
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 62
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 61
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 61
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 61
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 61
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 60
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 60
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 60
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 59
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 59
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 59
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance 58
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 58
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 58
New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing. Antibiotics 58
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 57
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 56
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 56
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 56
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 55
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 55
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 55
New Skin Toxicities for New Anticancer Therapies 53
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 53
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. 53
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 53
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 53
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 51
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background 50
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 50
Topical application of fumaric acid esters improves appearance of nail psoriasis 47
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 46
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 46
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 45
Phototherapy in Dermatology 45
Expression of Paraoxonase-2 in Different Stages of Cutaneous T Cell Lymphoma: Is It a Potential Biomarker for Aggressiveness? 44
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study. 43
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 41
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 41
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 40
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 39
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 39
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 38
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 37
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 36
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 36
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 36
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 35
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 34
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 34
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 31
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 29
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 28
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 27
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 26
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 25
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 25
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 25
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease 24
Trichorhinophalangeal syndrome: a case report and brief literature review. 23
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 22
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 22
null 22
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 22
Totale 5.755
Categoria #
all - tutte 43.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 0 0 0 0 60 4 44 17 48 6 23 55
2020/2021887 43 68 73 11 76 84 112 47 67 92 155 59
2021/2022693 16 100 27 12 29 46 25 53 47 28 137 173
2022/20231.943 133 190 123 179 114 503 8 107 386 10 130 60
2023/20241.291 162 25 151 136 166 296 27 71 19 86 16 136
2024/2025650 318 181 75 37 39 0 0 0 0 0 0 0
Totale 6.099